PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Apellis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
PRICE T ROWE ASSOCIATES INC | 2,749,542 2.500% |
-2,557,944 (-48.20%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
PRICE T ROWE ASSOCIATES INC | 5,307,486 5.400% |
5,307,486 (New Position) |
Filing |